Lipocine Inc. (LPCN) is on the roll with an average volume of 1.51M in the recent 3 months

At the end of the latest market close, Lipocine Inc. (LPCN) was valued at $1.34. In that particular session, Stock kicked-off at the price of $1.34 while reaching the peak value of $1.36 and lowest value recorded on the day was $1.30. The stock current value is $1.27.

Recently in News on July 13, 2020, Lipocine Regains Complinace With Nasdaq Minimum Bid Price Requirement. Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) on July 9, 2020 indicating that Lipocine has regained compliance with Nasdaq’s minimum bid price for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(a)(2) (“Min Bid Price Listing Rule”). You can read further details here

Lipocine Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5000 on 07/06/20, with the lowest value was $0.3010 for the same time period, recorded on 03/18/20.

Lipocine Inc. (LPCN) full year performance was -25.14%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Lipocine Inc. shares are logging -63.29% during the 52-week period from high price, and 320.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.30 and $3.45.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1099988 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Lipocine Inc. (LPCN) recorded performance in the market was 248.14%, having the revenues showcasing 185.29% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 63.70M, as it employees total of 12 workers.

Market experts do have their say about Lipocine Inc. (LPCN)

During the last month, 0 analysts gave the Lipocine Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7231, with a change in the price was noted +0.7745. In a similar fashion, Lipocine Inc. posted a movement of +162.88% for the period of last 100 days, recording 1,581,905 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for LPCN is recording 0.97 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.71.

Technical breakdown of Lipocine Inc. (LPCN)

Raw Stochastic average of Lipocine Inc. in the period of last 50 days is set at 73.96%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.32%. In the last 20 days, the company’s Stochastic %K was 71.26% and its Stochastic %D was recorded 74.90%.

Bearing in mind the latest performance of Lipocine Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 248.14%. Additionally, trading for the stock in the period of the last six months notably improved by 226.67%, alongside a downfall of -25.14% for the period of the last 12 months. The shares increased approximately by 2.29% in the 7-day charts and went down by 38.14% in the period of the last 30 days. Common stock shares were driven by 185.29% during last recorded quarter.